Megan H. Bair-Merritt

Epidemiology · 2009–2015

A researcher in the Science corpus: 3 papers; trusts 20 researchers and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

Whom Megan H. Bair-Merritt trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. Estes
  2. David Moher
  3. Mustafa S. Ascha
  4. Giulio Marchesini
  5. Z. Younossi
  6. A. Liberati
  7. H. Razavi
  8. I. Hanouneh
  9. Q. Anstee
  10. J. Tetzlaff

Who trusts Megan H. Bair-Merritt overall

  1. Cortney A. Franklin
  2. Mikel Hernandez
  3. G. Kercher
  4. A. Gomez
  5. Gorka Epelde
  6. Farnaz Kaighobadi
  7. Ane Alberdi
  8. H. Tınmaz
  9. A. Andermann
  10. T. Bryant-Davis

Papers from Megan H. Bair-Merritt's perspective

Ordered by how strongly the researchers Megan H. Bair-Merritt trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
  2. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
  3. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (Nature Reviews Gastroenterology &Hepatology)
  4. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe (Hepatology)
  5. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. (Diabetes)
  6. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. (Journal of Hepatology)
  7. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up (Hepatology)
  8. Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: Systematic Review and Meta-analysis (Hepatology)
  9. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (British medical journal)
  10. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease (Hepatology)

Their papers